Ulwazi olusisiseko
| Igama lemveliso | Ikhathalogu | Uhlobo | Umamkeli/uMthombo | Ukusetyenziswa | Usetyenziso | I-Epitope | I-COA |
| I-HEV Antigen | BMHEV110 | I-Antigen | E.coli | Bamba | ELISA, CLIA, WB | / | Khuphela |
| I-HEV Antigen | BMHEV112 | I-Antigen | E.coli | Hlanganisa | ELISA, CLIA, WB | / | Khuphela |
| I-HEV-HRP | BMHEV114 | I-Antigen | E.coli | Hlanganisa | ELISA, CLIA, WB | / | Khuphela |
IHepatitis E (iHepatitis E) sisifo esosulelayo esinamandla esisasazwa lindle.Ukususela ekuqhambukeni kokuqala kwe-hepatitis E kwenzeka eIndiya ngo-1955 ngenxa yongcoliseko lwamanzi, iye yaxhaphaka eIndiya, Nepal, Sudan, Kyrgyzstan of the Soviet Union, Xinjiang kunye nezinye iindawo e-China.
IHepatitis E (iHepatitis E) sisifo esosulelayo esinamandla esisasazwa lindle.
Jonga:
① Ukufunyanwa kwe-serum ye-anti HEV IgM kunye ne-anti HEV IgG: ukufunyanwa kwe-EIA.I-Serum anti HEV IgG yafunyanwa emva kweentsuku ezi-7 emva kokuqala kwesi sifo, enye yeempawu zosulelo lwe-HEV;
② Ukufunyanwa kwe-HEV RNA kwi-serum kunye nesitulo: ngokuqhelekileyo ukuqokelela iisampulu kwinqanaba lokuqala lesi sifo kwaye usebenzise i-RT-PCR
